Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Surgery. 2021 Jun 17;170(4):1031–1038. doi: 10.1016/j.surg.2021.05.020

Table 3 –

Risk-Adjusted Relationship between Team Familiarity and Study Outcomes by EuroSCORE-II Risk

Overall EuroSCORE-II Strata
Low (<2.2%) Medium (2.2%−6.9%) High (>6.9%)
Outcome Measure of Association# p-value Measure of Association# p-value Measure of Association# p-value Measure of Association# p-value
Primary
Cardiopulmonary Bypass Duration, minutes −0.189 0.213 −0.272 0.077 −0.978 <.0001
Secondary
Intensive Care Units, hours −0.173 0.346
Ventilation hours −0.461 0.017
Major Morbidity (%) 0.966 0.001 1.018 0.014 0.992 0.186
 Prolonged Ventilation 0.956 0.002 1.021 0.012 0.996 0.494
 Deep Sternal Wound Infection 0.977 0.505
 Permanent Stroke 0.987 0.691 1.025 0.190 0.965 0.049
 Reoperation 0.981 0.082
 Renal Failure 0.991 0.304
Acute Kidney Injury (Stage 2 or 3) 0.993 0.259
Acute Kidney Injury (Stage 3) 0.991 0.272
30 day Mortality 0.987 0.244

Measures of Association#: Beta coefficients are presented for continuous measures: cardiopulmonary bypass duration (minutes), intensive care unit (hours) and ventilation (hours). Odds ratios are presented for the binary outcome measures.

Major morbidity includes any of the following: renal failure, prolonged ventilation, deep sternal wound infection, stroke, unplanned reoperation

*

When the interaction term with EuroSCORE-II is significant, overall association is reported. When the interaction term with EuroSCORE-II is not significant, EuroSCORE-II strata specific associations are reported. Thus, some of the cells are shaded when not reported.